(Isstories Editorial):- Cambridge, Massachusetts Sep 17, 2023 (Issuewire.com) – Andarix Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for rare cancers announced today that its CEO, Chris Adams will Chair the two days conference on rare diseases. The conference will include attendees from industry experts to patient groups.
The
More on Isstories:
